Murata Manufacturing Co., Ltd. (MRAAY)

Verve Therapeutics Revenue

Murata Manufacturing had revenue of 416.15B JPY in the quarter ending June 30, 2025, a decrease of -1.32%. This brings the company's revenue in the last twelve months to 1.74T, up 2.58% year-over-year. In the fiscal year ending March 31, 2025, Murata Manufacturing had annual revenue of 1.74T with 6.29% growth.

• Revenue (ttm): 1,737.80B JPY
• Revenue Growth: +2.58%
• P/S Ratio: 2.40
• Revenue / Employee: 23.95M JPY
• Employees: 72,572
• Market Cap: 28.96B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1,743.35B	103.19B	6.29%
Mar 31, 2024	1,640.16B	-46.64B	-2.76%
Mar 31, 2023	1,686.80B	-125.73B	-6.94%
Mar 31, 2022	1,812.52B	182.33B	11.18%
Mar 31, 2021	1,630.19B	96.15B	6.27%